TCL Archive Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer November 20, 1992
TCL Archive Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent. February 24, 2006
TCL Archive In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent November 27, 1987
